text

Platform

content-image
GenVivo’s Innovative Oncology Gene Medicine Platform

GenVivo’s platform has been meticulously engineered to overcome key challenges of past vector-based immunotherapy approaches. Our non-replicating retrovector-based platform is designed to deliver therapeutic genes through systemic administration over multiple doses.

Platform Advantages and Safety
text
text

Our versatile platform allows for both an integrating approach for oncology applications, as well as a non-integrating option for infectious disease applications.

We maintain control of our platform in-house from R&D engineering to producing cGMP drug product for clinical trials.

text
Created with BioRender.com
text
Created with BioRender.com